• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    CORE LAB REPORTS FIRST QUARTER 2024 RESULTS

    4/24/24 5:15:00 PM ET
    $CLB
    Oilfield Services/Equipment
    Energy
    Get the next $CLB alert in real time by email
    • FIRST QUARTER REVENUE OF $129.6 MILLION, UP MODESTLY SEQUENTIALLY AND YEAR-OVER-YEAR
    • FIRST QUARTER OPERATING INCOME OF $8.6 MILLION; EX-ITEMS, $14.9 MILLION, FLAT SEQUENTIALLY, UP 3% YEAR-OVER-YEAR
    • FIRST QUARTER OPERATING MARGINS, EX-ITEMS, OF 12%
    • FIRST QUARTER GAAP EPS OF $0.07; EX-ITEMS, $0.19, FLAT SEQUENTIALLY AND YEAR-OVER-YEAR
    • FIRST QUARTER FREE CASH FLOW OF $2.5 MILLION
    • COMPANY ANNOUNCES Q2 2024 QUARTERLY DIVIDEND

    HOUSTON, April 24, 2024 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2024 revenue of $129,600,000.  Core's operating income was $8,600,000, with diluted earnings per share ("EPS") of $0.07, all in accordance with U.S. generally accepted accounting principles ("GAAP").  Operating income, ex-items, a non-GAAP financial measure, was $14,900,000, yielding operating margins of 12%, and EPS, ex-items, of $0.19.  During the first quarter of 2024, the Company recorded: 1) approximately $3,500,000 of non-cash stock compensation expense associated with full recognition of unvested awards for employees who have reached their eligible retirement age, and 2) employee severance, facility exit and consolidation expenses of $2,600,000.  A full reconciliation of non-GAAP financial measures is included in the attached financial tables.

    Core's CEO, Larry Bruno stated, "Core Lab delivered modest revenue growth and overcame the typical sequential seasonal decline in client activity that we often experience between the fourth and first quarters.  Strong demand for both our Reservoir Description laboratory services and Production Enhancement's completion diagnostic services drove the quarter. Core's investments to expand laboratory capabilities in the Middle East and other international markets prior to and during the global pandemic are now delivering results, as long-delayed client analytical projects progress into the early stages of execution.  We expect that these prior investments in international growth opportunities will generate superior, long-term returns. Production Enhancement's sequential financial performance was driven by higher demand for both U.S. and international completion diagnostics, as Core's clients seek to evaluate new completion designs for optimizing hydrocarbon production.  Despite quarter-over-quarter softness in U.S. completion activity, U.S. product sales also improved sequentially.  Core Lab used excess free cash to reduce debt by $3,000,000 in the first quarter of 2024, and will continue to remain focused on executing strategic business initiatives while reducing our leverage ratio."

    Reservoir Description

    Reservoir Description operations are closely correlated with trends in international and offshore activity levels, with approximately 80% of revenue sourced from projects originating outside the U.S.  Revenue in the first quarter of 2024 was $84,200,000, flat sequentially and an increase of 5% from last year.  Operating income on a GAAP basis was $6,900,000, while operating income, ex-items, was $11,400,000, yielding operating margins of 14%.  The segment's financial performance in the first quarter of 2024 reflects a year-over-year increase in demand for reservoir rock and fluid analysis in both international and U.S. markets.  This growth helped offset both the typical seasonal decline in client activity that occurs between the fourth and first quarters, as well as on-going disruptions to hydrocarbon transportation and trading patterns caused by the Middle East and Russia-Ukraine conflicts.  While operating margins remained strong at 14%, sequential margins were somewhat impacted by the mix of services delivered to Core's clients compared to the fourth quarter of 2023.

    During the first quarter of 2024, Core Laboratories continued to experience increased industry adoption of its proprietary web-enabled data management system, RAPID™.  A significant milestone was achieved with the successful installation of RAPID™ by a prominent Middle Eastern National Oil Company ("NOC").  The installation, as part of a platform demonstration, rigorously tested the system's functionality and is providing the NOC with centralized, consistent, and easily accessible subsurface data in a secure format.  RAPID™ empowers clients to efficiently organize, retrieve, archive and analyze vast amounts of geological, petrophysical, reservoir engineering and reservoir fluid data.  The database facilitates sophisticated queries through a user-friendly interface, enhancing various predictive and Artificial Intelligence ("AI") innovations.  Utilizing RAPID™ as the primary platform for subsurface data management within this NOC allows for a more robust digital environment for future AI projects.  Core Lab continues its leadership position in the digitization of the oil field, bridging data analytical tools with digitally delivered and archived data.

    Also during the first quarter of 2024, Core Lab was engaged to evaluate conventional cores from the North Slope region of Alaska.  This project brought together Core's proprietary and patented technologies to help the client optimize their reservoir.  By using a combination of drilling mud tracers from Core's Production Enhancement segment, along with proprietary laboratory technologies from Reservoir Description, Core's InvasionProfiler™ technology package allowed the operator to quantify the invasion of drilling mud filtrate.  The client will use this data to refine their reservoir model with tracer-corrected fluid saturation data.  A laboratory program is also under way on the recovered reservoir fluids from this project to determine the chemical and physical properties of the hydrocarbons.  This comprehensive rock and fluid analytical program provides the hard data points required to define pay zones, build and de-risk reservoir models, and predict reservoir performance.

    Production Enhancement

    Production Enhancement operations, which are focused on complex completions in unconventional oil and gas reservoirs in the U.S., as well as conventional projects across the globe, posted first quarter 2024 revenue of $45,400,000, up over 4% sequentially.  The sequential financial performance reflects both higher demand for completion diagnostic services as well as improved penetration of completion products in the U.S., despite a quarter-over-quarter decline in completion activity.  Operating income on a GAAP basis was $1,600,000, while operating income, ex-items, was $3,400,000, yielding operating margins of 8%, an improvement of 200 basis points sequentially, with incremental margins exceeding 55%.

    In the first quarter of 2024, Core Lab's Production Enhancement engineers introduced new capabilities for its proprietary downhole Metal Anomaly Tool technology.  The Metal Anomaly Tool ("MAT") is used when preferential alignment of perforating guns are required to ensure that casing clamps, data cables and control lines are not cut during the perforating process.  The MAT technology measures magnetic fields induced during fluid flow around protrusions that surround the casing, such as those caused by clamps and lines.  However, certain reservoir applications require the use of high-chromium-content well casing to mitigate corrosion, such as where CO2 or H2S are present in high concentrations. High-chromium-content casing has historically created limitations for the MAT technology, as the metallurgy attenuates the magnetic field peripheral to the casing.  Core's engineers developed a proprietary solution that allows the MAT technology to identify clamps, cables and lines behind high-chromium-content casing, reducing operational risks in real time. 

    Also during the first quarter of 2024, Core's diagnostic technologies were employed in two mature U. S. basins to assess high-profile well completions.  In the Eagle Ford, an operator needed to confirm the performance of refrac treatments in horizontal wells. The operator enlisted Core Lab to run its SpectraChem® water tracers to confirm frac fluid placement and fluid flowback from each of the twenty-one treatment stages.  After the frac job, produced water samples indicated effective treatment placement and flowback from each refrac stage with one exception. The outermost toe stage demonstrated a steep production drop compared to the remainder of the re-completed lateral.  Further analysis indicated there was an obstruction in the toe of the well.  The operator performed a remedial procedure to remove the obstruction, and production from the toe stage reached a level of contribution commensurate with the remainder of the well.  In the Permian Basin, Core's proprietary technologies were utilized to evaluate the effectiveness of a surfactant additive in horizontal well frac treatments.  The objective was to determine if the surfactant would improve oil recovery in this very tight shale strata.  The operator wanted to determine the efficacy of the product without having to perform long-term, multi-well, post-frac comparisons.  The operator enlisted Core to run its proprietary Flow Profiler™ oil tracer diagnostics across the length of the well to compare production from treated and untreated stages.  The produced oil samples indicated higher oil contributions from the surfactant-treated stages.  This enabled the operator to quickly take advantage of this beneficial, and environmentally friendly, surfactant in upcoming wells.

    Liquidity, Free Cash Flow and Dividend

    Core continues to focus on maximizing free cash flow ("FCF"), a non-GAAP financial measure defined as cash from operations less capital expenditures.  For the first quarter of 2024, cash from operations was approximately $5,500,000 and capital expenditures were $3,000,000, yielding FCF of $2,500,000.  Cash from operations was impacted by an increase in working capital, as accounts receivable grew by $5,700,000 during the quarter.  The growth in accounts receivable occurred in March, reflecting strong sales in the U.S. market as we exited the quarter.

    Core expects the Company to continue generating positive free cash flow in future quarters. As of March 31, 2024, Core reduced debt by $3,000,000 from prior quarter-end to $163,000,000. The Company's leverage ratio of 1.76 was unchanged compared to prior quarter-end.  The Company will continue applying future free cash towards reducing debt until the Company reaches its target leverage ratio (calculated as total net debt divided by trailing twelve months adjusted EBITDA) of 1.5 times or lower.

    On January 31, 2024, Core's Board of Directors ("Board") announced a quarterly cash dividend of $0.01 per share of common stock, which was paid on March 4, 2024 to shareholders of record on February 12, 2024.  

    On April 24, 2024, the Board approved a cash dividend of $0.01 per share of common stock payable on May 28, 2024 to shareholders of record on May 6, 2024.   

    Return On Invested Capital

    The Board and the Company's Executive Management continue to focus on strategies that maximize return on invested capital ("ROIC") and FCF, factors that have high correlation to total shareholder return.   Core's commitment to an asset-light business model and disciplined capital stewardship promote capital efficiency and are designed to produce more predictable and superior long-term ROIC.

    The Board has established an internal metric to demonstrate ROIC performance relative to the oilfield service companies listed as Core's Comp Group by Bloomberg, as the Company continues to believe superior ROIC will result in higher total shareholder return.  Using Bloomberg's formula, the Company's ROIC for the first quarter of 2024 was 11.6% and remained  relatively flat compared to prior quarter-end.

    Industry and Core Lab Outlook and Guidance

    As 2024 unfolds, Core will continue to execute its strategic plan of technology investments targeted to both solve client problems and capitalize on Core's growth opportunities.  The Company will also remain focused on maximizing ROIC, generating free cash and reducing debt.  Core Lab maintains its constructive outlook on international upstream projects for 2024 and anticipates sustainable activity growth in the years ahead to support crude-oil demand and energy security concerns.  Year to date, crude-oil demand is performing as expected, with an increase in demand during the first three months of the year.  For the short and long term, increased investment in the development of onshore and offshore crude-oil fields will be required to maintain and grow hydrocarbon production.  In the near-term, crude-oil markets remain volatile due to global recession fears and the uncertainties related to on-going conflicts in Russia-Ukraine and the Middle East.   

    As international activity continues to expand, committed long-term upstream projects from the Middle East, South Atlantic Margin, certain areas of Asia Pacific and West Africa support year-over-year growth for Core Lab.  As such, Core anticipates Reservoir Description's second quarter 2024 revenue to continue growing; however, the geopolitical situations in Russia-Ukraine and the Middle East continue to create volatility with respect to trading patterns and maritime transportation of crude oil and derived products, potentially impacting demand for the lab services Core provides to these markets.  Turning to the U.S., frac spread activity peaked in the fall of 2022; however, the declines experienced in completion activity during 2023 appear to have stabilized.  Core Lab continues to project completion activity in 2024 to remain relatively flat compared to 2023.  However, market penetration of Core's proprietary energetic system and completion diagnostic service technologies are projected to outperform activity levels.

    Reservoir Description's second quarter 2024 revenue is projected to range from $85,500,000 to $88,500,000, with operating income of $12,700,000 to $14,400,000.  Core's Production Enhancement segment's second quarter 2024 revenue is estimated to range from $44,500,000 to $47,500,000, with operating income of $1,600,000 to $2,600,000.                      

    The Company's second quarter 2024 revenue is projected to range from $130,000,000 to $136,000,000, with operating income of $14,500,000 to $17,300,000, yielding operating margins of approximately 12%. EPS for the second quarter of 2024 is expected to be $0.19 to $0.23.

    The Company's second quarter 2024 guidance is based on projections for underlying operations and excludes gains and losses in foreign exchange.  Second quarter 2024 guidance also assumes an effective tax rate of 20%.

    Earnings Call Scheduled

    The Company has scheduled a conference call to discuss Core's first quarter 2024 earnings announcement.  The call will begin at 7:30 a.m. CDT / 8:30 a.m. EDT on Thursday, April 25, 2024. To listen to the call, please go to Core's website at www.corelab.com.

    Core Laboratories Inc. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance.  The Company has over 70 offices in more than 50 countries and is located in every major oil-producing province in the world. This release, as well as other statements we make, includes forward-looking statements regarding the Company's future revenue, profitability, business strategies and developments, demand for the Company's products and services and for products and services of the oil and gas industry generally, made in reliance upon the safe harbor provisions of Federal securities law. The Company's outlook is subject to various important cautionary factors, including risks and uncertainties related to the oil and natural gas industry, business and general economic conditions, including inflationary pressures, the ability to achieve the benefits of the redomestication of the parent company from the Netherlands to the United States, international markets, international political climates, including the Russia-Ukraine and the Middle East geopolitical conflicts, public health crises, and any related actions taken by businesses and governments, and other factors as more fully described in the Company's most recent Forms 10-K, 10-Q and 8-K filed with or furnished to the U.S. Securities and Exchange Commission. These important factors could cause the Company's actual results to differ materially from those described in these forward-looking statements. Such statements are based on current expectations of the Company's performance and are subject to a variety of factors, some of which are not under the control of the Company. Because the information herein is based solely on data currently available, and because it is subject to change as a result of changes in conditions over which the Company has no control or influence, such forward-looking statements should not be viewed as assurance regarding the Company's future performance.

    The Company undertakes no obligation to publicly update or revise any forward-looking statement to reflect events or circumstances that may arise after the date of this press release, except as required by law.

    Visit the Company's website at www.corelab.com. Connect with Core Lab on Facebook, LinkedIn and YouTube.

     

    CORE LABORATORIES INC. & SUBSIDIARIES

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (In thousands, except per share data)

    (Unaudited)







    Three Months Ended





    % Variance





    March 31,

    2024





    December 31,

    2023





    March 31,

    2023





    vs. Q4-23



    vs. Q1-23

    REVENUE



    $

    129,637





    $

    128,210





    $

    128,356





    1.1 %



    1.0 %





























    OPERATING EXPENSES:



























    Costs of services and product sales





    104,588







    101,517







    101,528





    3.0 %



    3.0 %

    General and administrative expense





    11,789







    8,665







    16,331





    36.1 %



    (27.8) %

    Depreciation and amortization





    3,843







    3,874







    4,044





    (0.8) %



    (5.0) %

    Other (income) expense, net





    846







    (427)







    (28)





    NM



    NM

    Total operating expenses





    121,066







    113,629







    121,875





    6.5 %



    (0.7) %





























    OPERATING INCOME





    8,571







    14,581







    6,481





    (41.2) %



    32.2 %

    Interest expense





    3,423







    3,618







    3,429





    (5.4) %



    (0.2) %

    Income before income taxes





    5,148







    10,963







    3,052





    (53.0) %



    68.7 %

    Income tax expense





    1,658







    8,529







    610





    (80.6) %



    171.8 %

    Net income





    3,490







    2,434







    2,442





    43.4 %



    42.9 %

    Net income attributable to non-controlling interest





    270







    235







    69





    NM



    NM

    Net income attributable to Core Laboratories Inc.



    $

    3,220





    $

    2,199





    $

    2,373





    46.4 %



    35.7 %





























    Diluted earnings per share



    $

    0.07





    $

    0.05





    $

    0.05





    40.0 %



    40.0 %





























    Diluted earnings per share attributable to Core Laboratories Inc.



    $

    0.07





    $

    0.05





    $

    0.05





    40.0 %



    40.0 %





























    Diluted weighted average common shares outstanding





    47,703







    47,557







    47,481





    0.3 %



    0.5 %





























    Effective tax rate





    32

    %





    78

    %





    20

    %



    NM



    NM





























    SEGMENT INFORMATION:























































    Revenue:



























    Reservoir Description



    $

    84,236





    $

    84,628





    $

    80,188





    (0.5) %



    5.0 %

    Production Enhancement





    45,401







    43,582







    48,168





    4.2 %



    (5.7) %

    Consolidated



    $

    129,637





    $

    128,210





    $

    128,356





    1.1 %



    1.0 %





























    Operating income:



























    Reservoir Description



    $

    6,892





    $

    12,259





    $

    2,471





    (43.8) %



    178.9 %

    Production Enhancement





    1,576







    2,195







    3,281





    (28.2) %



    (52.0) %

    Corporate and Other





    103







    127







    729





    NM



    NM

    Consolidated



    $

    8,571





    $

    14,581





    $

    6,481





    (41.2) %



    32.2 %





























    "NM" means not meaningful



























     

    CORE LABORATORIES INC. & SUBSIDIARIES

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (In thousands)

    (Unaudited) 



















    % Variance

    ASSETS:



    March 31,

    2024





    December 31,

    2023





    vs. Q4-23



















    Cash and cash equivalents



    $

    14,913





    $

    15,120





    (1.4) %

    Accounts receivable, net





    115,092







    109,352





    5.2 %

    Inventories





    70,711







    71,702





    (1.4) %

    Other current assets





    28,331







    26,962





    5.1 %

    Total current assets





    229,047







    223,136





    2.6 %



















    Property, plant and equipment, net





    98,521







    99,626





    (1.1) %

    Right of use assets





    53,636







    53,842





    (0.4) %

    Intangibles, goodwill and other long-term assets, net





    206,746







    209,791





    (1.5) %

    Total assets



    $

    587,950





    $

    586,395





    0.3 %



















    LIABILITIES AND EQUITY:



































    Accounts payable



    $

    32,486





    $

    33,506





    (3.0) %

    Short-term operating lease liabilities





    10,430







    10,175





    2.5 %

    Other current liabilities





    42,552







    44,416





    (4.2) %

    Total current liabilities





    85,468







    88,097





    (3.0) %



















    Long-term debt, net





    160,370







    163,134





    (1.7) %

    Long-term operating lease liabilities





    41,481







    42,076





    (1.4) %

    Other long-term liabilities





    63,214







    63,281





    (0.1) %



















    Total equity





    237,417







    229,807





    3.3 %























    Total liabilities and equity



    $

    587,950





    $

    586,395





    0.3 %

     

    CORE LABORATORIES INC. & SUBSIDIARIES

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (In thousands)

    (Unaudited)







    Three Months Ended March 31,







    2024





    2023



    CASH FLOWS FROM OPERATING ACTIVITIES:













    Net income



    $

    3,490





    $

    2,442



    Adjustments to reconcile net income to net cash provided by (used in) operating activities:













    Stock-based compensation





    4,820







    8,984



    Depreciation and amortization





    3,843







    4,044



    Deferred income taxes





    2,827







    936



    Accounts receivable





    (6,290)







    (4,024)



    Inventories





    991







    (6,897)



    Accounts payable





    (551)







    (7,078)



    Other adjustments to net income





    (3,600)







    (1,576)



    Net cash provided by (used in) operating activities





    5,530







    (3,169)

















    CASH FLOWS FROM INVESTING ACTIVITIES:













    Capital expenditures





    (3,052)







    (2,208)



    Net proceeds on life insurance policies





    805







    —



    Other investing activities





    590







    170



    Net cash provided by (used in) investing activities





    (1,657)







    (2,038)

















    CASH FLOWS FROM FINANCING ACTIVITIES:













    Repayment of long-term debt





    (17,000)







    (16,000)



    Proceeds from long-term debt





    14,000







    24,000



    Dividends paid





    (468)







    (466)



    Repurchase of common stock





    (44)







    (1)



    Equity related transaction costs





    (549)







    (1,285)



    Other financing activities





    (19)







    (184)



    Net cash provided by (used in) financing activities





    (4,080)







    6,064

















    NET CHANGE IN CASH AND CASH EQUIVALENTS





    (207)







    857



    CASH AND CASH EQUIVALENTS, beginning of period





    15,120







    15,428



    CASH AND CASH EQUIVALENTS, end of period



    $

    14,913





    $

    16,285



    Non-GAAP Information

    Management believes that the exclusion of certain income and expenses enables it to evaluate more effectively the Company's operations period-over-period and to identify operating trends that could otherwise be masked by the excluded Items. For this reason, management uses certain non-GAAP measures that exclude these Items and believes that this presentation provides a clearer comparison with the results reported in prior periods. The non-GAAP financial measures should be considered in addition to, and not as a substitute for, the financial results prepared in accordance with GAAP, as more fully discussed in the Company's financial statements and filings with the Securities and Exchange Commission.

     

    Reconciliation of Operating Income, Net Income and Diluted Earnings Per Share Attributable to Core Laboratories Inc.

    (In thousands, except per share data)

    (Unaudited)







    Operating Income







    Three Months Ended







    March 31,

    2024





    December 31,

    2023





    March 31,

    2023



    GAAP reported



    $

    8,571





    $

    14,581





    $

    6,481



    Stock compensation (1)





    3,458







    —







    6,515



    Loss on lease abandonment and assets write-down (2)





    1,809







    —







    1,656



    Severance costs





    824







    —







    —



    Foreign exchange losses (gains)





    285







    468







    (144)



    Excluding specific items



    $

    14,947





    $

    15,049





    $

    14,508











    Net Income Attributable to Core Laboratories Inc.







    Three Months Ended







    March 31,

    2024





    December 31,

    2023





    March 31,

    2023



    GAAP reported



    $

    3,220





    $

    2,199





    $

    2,373



    Stock compensation (1)





    2,766







    —







    5,212



    Loss on lease abandonment and assets write-down (2)





    1,447







    —







    1,325



    Severance costs





    659







    —







    —



    Foreign exchange losses (gains)





    229







    374







    (114)



    Reversal of net deferred tax liabilities and effect of higher (lower) tax rate (3)





    628







    6,336







    —



    Excluding specific items



    $

    8,949





    $

    8,909





    $

    8,796











    Diluted Earnings Per Share Attributable to Core Laboratories Inc.







    Three Months Ended







    March 31,

    2024





    December 31,

    2023





    March 31,

    2023



    GAAP reported



    $

    0.07





    $

    0.05





    $

    0.05



    Stock compensation (1)





    0.06







    —







    0.11



    Loss on lease abandonment and assets write-down (2)





    0.03







    —







    0.03



    Severance costs





    0.01







    —







    —



    Foreign exchange losses (gains)





    0.01







    0.01







    —



    Reversal of net deferred tax liabilities and effect of higher (lower) tax rate (3)





    0.01







    0.13







    —



    Excluding specific items



    $

    0.19





    $

    0.19





    $

    0.19























    (1) Three months ended March 31, 2024 and 2023 includes the acceleration of stock compensation expense associated with employees reaching eligible retirement age.

    (2) Three months ended March 31, 2024 and 2023 include the write-down of leasehold improvements, right of use assets and/or other assets and exit costs associated with consolidation of certain facilities.

    (3) Three months ended March 31, 2024 includes the effect to reflect tax expense at a normalized rate of 20%. Three months ended December 31, 2023 includes the reversal of certain deferred tax assets and liabilities which will not be realized as a result of the Redomsestication Transaction and the effect to reflect tax expense at a normalized rate of 20%.

     

    Segment Information

    (In thousands)

    (Unaudited)







    Operating Income







    Three Months Ended March 31, 2024







    Reservoir

    Description





    Production

    Enhancement





    Corporate and

    Other



    GAAP reported



    $

    6,892





    $

    1,576





    $

    103



    Stock compensation (1)





    2,258







    1,200







    —



    Loss on lease abandonment and assets write-down (2)





    1,566







    243







    —



    Severance costs





    467







    357







    —



    Foreign exchange losses (gains)





    246







    38







    1



    Excluding specific items



    $

    11,429





    $

    3,414





    $

    104



    (1) Includes the acceleration of stock compensation expense associated with employees reaching eligible retirement age.



    (2) Includes the write-down of leasehold improvements, right of use assets and/or other assets and exit costs associated with consolidation of certain facilities.



    Return on Invested Capital

    Return on Invested Capital ("ROIC") is presented based on management's belief that this non-GAAP measure is useful information to investors and management when comparing profitability and the efficiency with which capital has been employed over time relative to other companies. The Board has established an internal metric to demonstrate ROIC performance relative to the oilfield service companies listed as Core's Comp Group by Bloomberg. ROIC is not a measure of financial performance under GAAP and should not be considered as an alternative to net income.

    ROIC of 11.6% is defined by Bloomberg as Net Operating Profit After Tax ("NOPAT") of $46.9 million divided by Average Total Invested Capital ("Average TIC") of $403.0 million where NOPAT is defined as GAAP net income before non-controlling interest plus the sum of income tax expense, interest expense, and pension expense less pension service cost and tax effect on income before interest and tax expense for the last four quarters. Average TIC is defined as the average of beginning and ending periods' GAAP stockholders' equity plus the sum of net long-term debt, lease liabilities, allowance for credit losses, net of deferred taxes, and income taxes payable.

    Free Cash Flow

    Core uses the non-GAAP financial measure of free cash flow to evaluate its cash flows and results of operations. Free cash flow is an important measurement because it represents the cash from operations, in excess of capital expenditures, available to operate the business and fund non-discretionary obligations. Free cash flow is not a measure of operating performance under GAAP and should not be considered in isolation nor construed as an alternative consideration to operating income, net income, or cash flows from operating, investing, or financing activities, each as determined in accordance with GAAP. Free cash flow should not be considered a measure of liquidity. Moreover, since free cash flow is not a measure determined in accordance with GAAP and thus is susceptible to varying interpretations and calculations, free cash flow as presented may not be comparable to similarly titled measures presented by other companies.

    Computation of Free Cash Flow

    (In thousands)

    (Unaudited)







    Three Months Ended









    March 31, 2024





    Net cash provided by operating activities



    $

    5,530





    Capital expenditures





    (3,052)





    Free cash flow



    $

    2,478





     

    Core Laboratories logo (PRNewsFoto/Core Laboratories) (PRNewsfoto/Core Laboratories)

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/core-lab-reports-first-quarter-2024-results-302126655.html

    SOURCE Core Laboratories Inc

    Get the next $CLB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CLB

    DatePrice TargetRatingAnalyst
    3/12/2025$15.00 → $16.00Sell → Neutral
    Citigroup
    6/30/2023$22.00 → $21.00Neutral → Sell
    Citigroup
    4/18/2023$21.50Neutral → Underperform
    BofA Securities
    1/9/2023Underperform → Neutral
    BofA Securities
    10/7/2022$24.00 → $17.00Sell → Neutral
    Citigroup
    9/26/2022$20.00Equal-Weight → Underweight
    Morgan Stanley
    4/18/2022$19.50 → $21.30Neutral → Underweight
    Piper Sandler
    1/18/2022$32.00 → $30.00Equal-Weight
    Morgan Stanley
    More analyst ratings

    $CLB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Core Laboratories Inc. (Amendment)

      SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)

      6/12/23 4:02:30 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • SEC Form SC 13G/A filed by Core Laboratories N.V. (Amendment)

      SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)

      2/14/23 4:08:12 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • SEC Form SC 13G/A filed by Core Laboratories N.V. (Amendment)

      SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)

      2/14/23 9:10:51 AM ET
      $CLB
      Oilfield Services/Equipment
      Energy

    $CLB
    Financials

    Live finance-specific insights

    See more
    • CORE LAB REPORTS FIRST QUARTER 2025 RESULTS

      REVENUE OF $123.6 MILLION, DOWN 4% SEQUENTIALLY AND 5% YEAR-OVER-YEAROPERATING INCOME OF $4.4 MILLION; EX-ITEMS, $11.8 MILLION, DOWN 25% SEQUENTIALLY AND 21% YEAR-OVER-YEAROPERATING MARGINS, EX-ITEMS, OF 10% GAAP EPS OF $0.00; EX-ITEMS, $0.14, DOWN 35% SEQUENTIALLY, AND 25% YEAR-OVER-YEARFREE CASH FLOW OF $3.9 MILLION, UP OVER 50% YEAR-OVER-YEAR NET DEBT REDUCED BY $4.9 MILLION; DEBT LEVERAGE RATIO REMAINS AT 1.31 COMPANY REPURCHASED 131,598 SHARES OF COMMON STOCK, A VALUE OF $2.0 MILLION COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDEND HOUSTON, April 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2025 revenue of $123,6

      4/23/25 5:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • CORE LABORATORIES ANNOUNCES TIMING OF FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

      HOUSTON, March 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its first quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on April 24, 2025. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on April 23, 2025, and may be accessed through the Company's website at www.corelab.com. To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast, a replay

      3/24/25 4:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

      FOURTH QUARTER REVENUE OF $129.2 MILLION, DOWN 4% SEQUENTIALLY AND UP SLIGHTLY YEAR-OVER-YEARFOURTH QUARTER OPERATING INCOME OF $14.2 MILLION; EX-ITEMS, $15.7 MILLION, DOWN 14% SEQUENTIALLY, UP 4% YEAR-OVER-YEAR FOURTH QUARTER OPERATING MARGINS, EX-ITEMS, OF 12% FOURTH QUARTER GAAP EPS OF $0.15; EX-ITEMS, $0.22, DOWN 12% SEQUENTIALLY, UP 16% YEAR-OVER-YEAR FOURTH QUARTER FREE CASH FLOW OF $16.2 MILLION, UP OVER 50% SEQUENTIALLY DEBT LEVERAGE RATIO REDUCED TO 1.31, AND NET DEBT REDUCED BY $11.7 MILLION COMPANY REPURCHASED 264,982 SHARES OF COMMON STOCK, A VALUE OF $4.9 MILLION, DURING THE FOURTH QUARTER COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDENDFULL YEAR REVENUE OF $523.8 MILLION, UP 3%FULL

      1/29/25 5:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy

    $CLB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Core Labs upgraded by Citigroup with a new price target

      Citigroup upgraded Core Labs from Sell to Neutral and set a new price target of $16.00 from $15.00 previously

      3/12/25 7:22:24 AM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • Core Labs downgraded by Citigroup with a new price target

      Citigroup downgraded Core Labs from Neutral to Sell and set a new price target of $21.00 from $22.00 previously

      6/30/23 7:19:53 AM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • Core Labs downgraded by BofA Securities with a new price target

      BofA Securities downgraded Core Labs from Neutral to Underperform and set a new price target of $21.50

      4/18/23 9:05:50 AM ET
      $CLB
      Oilfield Services/Equipment
      Energy

    $CLB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $CLB
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $CLB
    SEC Filings

    See more
    • CAO & Treasurer Teo Sow Hang covered exercise/tax liability with 79 shares and converted options into 175 shares (SEC Form 4)

      4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)

      5/5/25 2:55:21 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • SVP, Gen Counsel & Secretary Tattoli Mark Damian covered exercise/tax liability with 178 shares and converted options into 450 shares, decreasing direct ownership by 1% to 16,072 units (SEC Form 4)

      4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)

      5/5/25 2:53:25 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • Director Temeng Kwaku converted options into 9,317 shares, increasing direct ownership by 57% to 25,528 units (SEC Form 4)

      4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)

      4/2/25 2:40:47 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • CORE LABORATORIES ANNOUNCES OPENING OF UNCONVENTIONAL CORE ANALYSIS LABORATORY IN SAUDI ARABIA

      HOUSTON, May 7, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") is pleased to announce the opening of its new Unconventional Core Analysis Laboratory in Dammam, Kingdom of Saudi Arabia. This state-of-the-art facility, developed in collaboration with Core's long-time partner, Abdulla Fouad Group, underscores the Company's commitment to advancing reservoir evaluation technologies in the Middle East. The Company's new analytical laboratory is equipped with advanced proprietary instrumentation designed to provide comprehensive core and fluid analysis services tailored to unconventional reservoirs. By bringing Core Lab's cutting-edge technologies t

      5/7/25 12:53:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • CORE LAB REPORTS FIRST QUARTER 2025 RESULTS

      REVENUE OF $123.6 MILLION, DOWN 4% SEQUENTIALLY AND 5% YEAR-OVER-YEAROPERATING INCOME OF $4.4 MILLION; EX-ITEMS, $11.8 MILLION, DOWN 25% SEQUENTIALLY AND 21% YEAR-OVER-YEAROPERATING MARGINS, EX-ITEMS, OF 10% GAAP EPS OF $0.00; EX-ITEMS, $0.14, DOWN 35% SEQUENTIALLY, AND 25% YEAR-OVER-YEARFREE CASH FLOW OF $3.9 MILLION, UP OVER 50% YEAR-OVER-YEAR NET DEBT REDUCED BY $4.9 MILLION; DEBT LEVERAGE RATIO REMAINS AT 1.31 COMPANY REPURCHASED 131,598 SHARES OF COMMON STOCK, A VALUE OF $2.0 MILLION COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDEND HOUSTON, April 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2025 revenue of $123,6

      4/23/25 5:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • CORE LABORATORIES ANNOUNCES TIMING OF FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

      HOUSTON, March 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its first quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on April 24, 2025. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on April 23, 2025, and may be accessed through the Company's website at www.corelab.com. To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast, a replay

      3/24/25 4:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • SEC Form 10-Q filed by Core Laboratories Inc.

      10-Q - Core Laboratories Inc. /DE/ (0001958086) (Filer)

      4/25/25 6:36:23 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • Core Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Core Laboratories Inc. /DE/ (0001958086) (Filer)

      4/23/25 4:41:18 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • SEC Form DEFA14A filed by Core Laboratories Inc.

      DEFA14A - Core Laboratories Inc. /DE/ (0001958086) (Filer)

      3/31/25 4:59:20 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy